Advertisement
Advertisement

PEN

PEN logo

Penumbra, Inc.

318.71
USD
Sponsored
+0.39
+0.12%
Jun 12, 16:00 UTC -4
Closed
exchange

After-Market

318.83

+0.12
+0.04%

Penumbra, Inc. Profile

About

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Info & Links

CEO

Adam Elsesser

Headquarters

One Penumbra Place
Alameda, CA 94502, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.penumbrainc.com

Auditor

PricewaterhouseCoopers LLP

Share holders

19

Employees

4,700

Penumbra, Inc. Statistics

Valuation Measures

Market Capitalization2

12.54B

Enterprise Value

12.32B

Enterprise Value/EBITDA(ttm)

60.35

Price to Earnings Ratio(ttm)

85.81

Price to Sales(ttm)

9.21

Price to Book(mrq)

9.04

Price to Cash(ytd)

76.65

Profitability

Gross Margin(ttm)

67.10%

Operating Margin(ttm)

10.76%

Profit Margin(ttm)

12.66%

Return on Equity(ttm)

11.41%

Return on Invested Capital(ttm)

13.21%

Return on Assets(ttm)

8.83%

Income Statement

Revenue(ttm)

1.45B

Revenue Per Share(ttm)

36.98

Gross Profit(ttm)

979.96M

EBITDA(ttm)3

204.16M

Net Income Available to Common(ttm)

171.05M

Diluted EPS(ttm)

4.52

Share Statistics

Beta (5Y Monthly)

0.84

52-Week Change

25.82%

S&P 500 52-Week Change

24.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

39.33M

Dividend Yield

0.00%

Float4

37.59M

% Held by Insiders

4.20%

% Held by Institutions

88.88%

Balance Sheet

Total Cash(mrq)

615.66M

Total Cash Per Share(mrq)

15.65

Total Debt(mrq)

22.61M

Total Debt/Equity(mrq)

1.62%

Current Ratio(mrq)

6.64%

Quick Ratio(mrq)

4.29%

Book Value Per Share(mrq)

36.39

Cash Flow

Operating Cash Flow Per Share(ytd)

6.07

Free Cash Flow(ytd)

174.93M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement